DK1567137T3 - Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner - Google Patents

Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner

Info

Publication number: DK1567137T3
Authority: DK; Denmark
Prior art keywords: resveratrol; manufacture; treatment; influenza virus; virus infections
Prior art date: 2002-11-06

Application number

DK03772659T

Other languages

Danish (da)

English (en)

Inventor

Enrico Garaci

Anna T Palamara

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-06

Filing date

2003-10-14

Publication date

2008-04-28

2003-10-14 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2008-04-28 Application granted granted Critical

2008-04-28 Publication of DK1567137T3 publication Critical patent/DK1567137T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK03772659T 2002-11-06 2003-10-14 Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner DK1567137T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT000562A ITRM20020562A1 (it)	2002-11-06	2002-11-06	Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
PCT/IT2003/000626 WO2004041260A1 (en)	2002-11-06	2003-10-14	Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections

Publications (1)

Publication Number	Publication Date
DK1567137T3 true DK1567137T3 (da)	2008-04-28

Family

ID=32310188

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03772659T DK1567137T3 (da)	2002-11-06	2003-10-14	Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner

Country Status (18)

Country	Link
US (1)	US8431617B2 (de)
EP (1)	EP1567137B1 (de)
JP (1)	JP4589118B2 (de)
KR (1)	KR101060331B1 (de)
AR (1)	AR041891A1 (de)
AT (1)	ATE381929T1 (de)
AU (1)	AU2003279551A1 (de)
CA (1)	CA2504872C (de)
CY (1)	CY1107302T1 (de)
DE (1)	DE60318327T2 (de)
DK (1)	DK1567137T3 (de)
ES (1)	ES2295660T3 (de)
IT (1)	ITRM20020562A1 (de)
MX (1)	MXPA05004628A (de)
PL (1)	PL217628B1 (de)
PT (1)	PT1567137E (de)
TW (1)	TWI337863B (de)
WO (1)	WO2004041260A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007057436A2 (en) *	2005-11-18	2007-05-24	Ares Trading S.A.	Interferon in influenza
US8629283B2 (en) *	2008-03-06	2014-01-14	Icahn School Of Medicine At Mount Sinai	Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof
US20100112099A1 (en) *	2008-11-04	2010-05-06	Metaproteomics, Llc	Phytochemical compositions and methods for activating amp-kinase
CA2744947A1 (en) *	2008-12-19	2010-10-28	The Regents Of The University Of California	Use of epidermal growth factor inhibitors in the treatment of viral infection
KR100950445B1 (ko)	2009-10-26	2010-04-02	주식회사 중앙백신연구소	감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
WO2011150413A1 (en)	2010-05-28	2011-12-01	Mount Sinai School Of Medicine	Antiviral compounds and uses thereof
WO2013049773A1 (en) *	2011-09-30	2013-04-04	Vanderbilt University	Antiviral therapies with phospholipase d inhibitors
ES2615630T3 (es)	2014-06-04	2017-06-07	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Formulaciones sólidas que contienen resveratrol y ácidos grasos poliinsaturados omega-3 (n-3 PUFA)
PT2952209T (pt)	2014-06-04	2018-05-09	Alfasigma Spa	Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral
EP3120842A1 (de) *	2015-07-20	2017-01-25	Opterion Health AG	Peritoneale therapeutische flüssigkeit
KR20170039456A (ko)	2015-10-01	2017-04-11	동아대학교 산학협력단	오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) *	2016-08-09	2018-02-15	株式会社ブレインヘルス	抗生物質含有組成物
CN108893558B (zh) *	2018-05-24	2022-04-05	江苏海宏制药有限公司	一种桑木液原液抗病毒实验方法以及装置
WO2021207094A1 (en) *	2020-04-05	2021-10-14	Mong Michael	Systems and methods for treating coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2778337B1 (fr) *	1998-05-05	2001-08-31	Inst Nat Sante Rech Med	Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es)	1999-07-30	2001-05-15	Procter & Gamble	Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
ATE281179T1 (de) *	1999-08-13	2004-11-15	Univ Maryland Biotech Inst	Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür

2002
- 2002-11-06 IT IT000562A patent/ITRM20020562A1/it unknown
2003
- 2003-10-14 WO PCT/IT2003/000626 patent/WO2004041260A1/en active IP Right Grant
- 2003-10-14 KR KR1020057007230A patent/KR101060331B1/ko active IP Right Grant
- 2003-10-14 DE DE60318327T patent/DE60318327T2/de not_active Expired - Lifetime
- 2003-10-14 US US10/533,942 patent/US8431617B2/en active Active
- 2003-10-14 MX MXPA05004628A patent/MXPA05004628A/es active IP Right Grant
- 2003-10-14 ES ES03772659T patent/ES2295660T3/es not_active Expired - Lifetime
- 2003-10-14 CA CA2504872A patent/CA2504872C/en not_active Expired - Lifetime
- 2003-10-14 PL PL377557A patent/PL217628B1/pl unknown
- 2003-10-14 EP EP03772659A patent/EP1567137B1/de not_active Expired - Lifetime
- 2003-10-14 JP JP2004549541A patent/JP4589118B2/ja not_active Expired - Lifetime
- 2003-10-14 AT AT03772659T patent/ATE381929T1/de active
- 2003-10-14 AU AU2003279551A patent/AU2003279551A1/en not_active Abandoned
- 2003-10-14 PT PT03772659T patent/PT1567137E/pt unknown
- 2003-10-14 DK DK03772659T patent/DK1567137T3/da active
- 2003-10-27 TW TW092129780A patent/TWI337863B/zh not_active IP Right Cessation
- 2003-11-05 AR ARP030104047A patent/AR041891A1/es unknown
2008
- 2008-03-12 CY CY20081100281T patent/CY1107302T1/el unknown

Also Published As

Publication number	Publication date
ATE381929T1 (de)	2008-01-15
DE60318327D1 (de)	2008-02-07
KR101060331B1 (ko)	2011-08-30
PT1567137E (pt)	2008-02-19
KR20050071627A (ko)	2005-07-07
EP1567137A1 (de)	2005-08-31
AR041891A1 (es)	2005-06-01
MXPA05004628A (es)	2005-09-08
EP1567137B1 (de)	2007-12-26
US20050239906A1 (en)	2005-10-27
JP4589118B2 (ja)	2010-12-01
ES2295660T3 (es)	2008-04-16
PL377557A1 (pl)	2006-02-06
TW200501935A (en)	2005-01-16
ITRM20020562A1 (it)	2004-05-07
CA2504872C (en)	2011-07-05
CA2504872A1 (en)	2004-05-21
TWI337863B (en)	2011-03-01
DE60318327T2 (de)	2008-12-18
WO2004041260A1 (en)	2004-05-21
US8431617B2 (en)	2013-04-30
AU2003279551A1 (en)	2004-06-07
PL217628B1 (pl)	2014-08-29
JP2006507295A (ja)	2006-03-02
CY1107302T1 (el)	2012-11-21

Publication	Publication Date	Title
DK1542748T3 (da)	2014-05-12	Engangssprøjte
IS7894A (is)	2005-06-14	Skammtaform með ofnæmisvaka
DK1545662T3 (da)	2020-05-25	Lægemiddelindgivelsessystem
DE602004018587D1 (de)	2009-02-05	Staubschützende Wegwerfmaske
DK1633726T3 (da)	2011-03-28	Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
DK1599186T3 (da)	2013-07-08	System til administration af transmukalt lægemiddel
NO20054608D0 (no)	2005-10-06	Influensavirusvaksine
NO20052058D0 (no)	2005-04-27	Behandling av influensa.
NO20016368D0 (no)	2001-12-27	Respiratorisk syncytialvirus-replikasjonsinhibitorer
NO20016369D0 (no)	2001-12-27	Respiratorisk syncytialvirus-replikasjonsinhibitorer
DK1928438T3 (da)	2013-04-22	Anvendelse af ibudilast til behandling af stofafhængighed
DK1567137T3 (da)	2008-04-28	Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner
DK1601359T3 (da)	2009-01-05	Væskeformige, farmaceutiske formuleringer af palonosetron
EE200300311A (et)	2003-10-15	Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DE602004012448D1 (de)	2008-04-24	Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus
DK2388315T3 (da)	2014-08-25	Anvendelse af et myxomvirus, som ikke eksprimerer funktionelt M135R, til terapeutisk behandling
DK1709075T3 (da)	2012-08-27	Behandling af virusinfektioner
CL2004000261A1 (es)	2005-03-18	Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
ES1053382Y (es)	2003-07-16	Protesis dilatadora del vestibulo nasal.
DE602004022810D1 (de)	2009-10-08	Mehrdosis-inhalator
DK1494650T3 (da)	2011-08-08	Farmaceutisk formulering, der indeholder melatonin
DK1541137T3 (da)	2010-04-26	Transdermalt delivery system af gestoden
DE112004000806D2 (de)	2006-01-19	Phenol urea/melamineformaldehydecopolymers, method for the production thereof and use of the same
ATE405844T1 (de)	2008-09-15	Unidirektionales zählwerk
DK1446131T3 (da)	2007-09-10	Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS